| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Zanotti Katherine S | Director | C/O EXACT SCIENCES CORP., 5505 ENDEAVOR LANE, MADISON | /s/ Katherine S. Zanotti by Mark Busch, attorney-in- fact | 16 Jun 2025 | 0001367313 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXAS | Common Stock | Award | $0 | +5,398 | +7.6% | $0.000000 | 75,966 | 12 Jun 2025 | Direct | F1 |
| transaction | EXAS | Common Stock | Sale | $170,612 | -3,207 | -4.2% | $53.20 | 72,759 | 13 Jun 2025 | Direct | F2 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy. |
| F2 | The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into on November 25, 2024. |
Exhibit 24 - Power of Attorney